ALLO
Allogene Therapeutics Inc.
$1.28
+$0.04(+3.66%)
46
Overall
60
Value
50
Tech
28
Quality
Market Cap
$253.73M
Volume
3.40M
52W Range
$0.86 - $3.78
Target Price
$7.56
EPS Estimates Overview
| Current Quarter | $-0.22 | Next Quarter | $-0.23 |
| Current Year | $-0.96 | Next Year | $-0.86 |
| QoQ Growth | -4.5% | YoY Growth | +10.4% |
| 3Y EPS CAGR | +11.3% | Target Price | $7.56 |
| Consensus | Buy | Upside | +492.9% |
EPS Historical Trend (5 Years)
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ALLO | $1.28 | +3.7% | 3.40M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Allogene Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW